Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.

Eli Lilly is the latest major pharmaceutical company to bring artificial intelligence (AI) to the healthcare sector. Eli Lilly (LLY -0.40%) is one of the hottest pharmaceutical companies in the world. The company is quickly gaining steam in the weight loss market thanks to its blockbuster drug, Mounjaro, and its sibling treatment, Zepbound. In addition, earlier this month a group of external advisors to the Food and Drug Administration (FDA) endorsed the use of Lilly's Alzheimer's candidate, donanemab. Whil ...